FilingSEC EDGAR8-K
BeyondSpring Completes Sale of Subsidiary Interests for Strategic Clinical Data Access
· SEC accepted
StageCompleted
Filing content
The company completed the sale of its subsidiary interests in exchange for strategic access to clinical data from the DUBLIN-4 trial in China.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…